chr13-83877373-TA-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001281503.2(SLITRK1):c.*2043delT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.44 ( 19515 hom., cov: 0)
Exomes 𝑓: 0.50 ( 0 hom. )
Consequence
SLITRK1
NM_001281503.2 3_prime_UTR
NM_001281503.2 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.680
Genes affected
SLITRK1 (HGNC:20297): (SLIT and NTRK like family member 1) This gene encodes a member of the SLITRK protein family. Members of this family are integral membrane proteins that are characterized by two N-terminal leucine-rich repeat (LRR) domains and a C-terminal region that shares homology with trk neurotrophin receptors. However, the protein encoded by this gene lacks the region of homology to neurotrophin receptors. This protein is thought to be involved in neurite outgrowth. Mutations in this gene may be associated with Tourette syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 13-83877373-TA-T is Benign according to our data. Variant chr13-83877373-TA-T is described in ClinVar as [Likely_benign]. Clinvar id is 312476.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.815 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLITRK1 | NM_001281503.2 | c.*2043delT | 3_prime_UTR_variant | 2/2 | ENST00000674365.1 | NP_001268432.1 | ||
SLITRK1 | NM_052910.2 | c.*2043delT | 3_prime_UTR_variant | 1/1 | NP_443142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLITRK1 | ENST00000674365 | c.*2043delT | 3_prime_UTR_variant | 2/2 | NM_001281503.2 | ENSP00000501349.1 | ||||
SLITRK1 | ENST00000377084 | c.*2043delT | 3_prime_UTR_variant | 1/1 | ENSP00000366288.2 |
Frequencies
GnomAD3 genomes AF: 0.443 AC: 67189AN: 151510Hom.: 19451 Cov.: 0
GnomAD3 genomes
AF:
AC:
67189
AN:
151510
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.500 AC: 1AN: 2Hom.: 0 Cov.: 0AC XY: 0AN XY: 0
GnomAD4 exome
AF:
AC:
1
AN:
2
Hom.:
Cov.:
0
AC XY:
0
AN XY:
0
Gnomad4 NFE exome
AF:
GnomAD4 genome AF: 0.444 AC: 67308AN: 151628Hom.: 19515 Cov.: 0 AF XY: 0.439 AC XY: 32520AN XY: 74096
GnomAD4 genome
AF:
AC:
67308
AN:
151628
Hom.:
Cov.:
0
AF XY:
AC XY:
32520
AN XY:
74096
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
1714
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Tourette syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at